215 related articles for article (PubMed ID: 18332429)
1. IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions.
Collin M; Shannon O; Björck L
Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4265-70. PubMed ID: 18332429
[TBL] [Abstract][Full Text] [Related]
2. EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity.
Allhorn M; Olsén A; Collin M
BMC Microbiol; 2008 Jan; 8():3. PubMed ID: 18182097
[TBL] [Abstract][Full Text] [Related]
3. Sugar-free antibodies--the bacterial solution to autoimmunity?
Allhorn M; Collin M
Ann N Y Acad Sci; 2009 Sep; 1173():664-9. PubMed ID: 19758213
[TBL] [Abstract][Full Text] [Related]
4. Human IgG/Fc gamma R interactions are modulated by streptococcal IgG glycan hydrolysis.
Allhorn M; Olin AI; Nimmerjahn F; Collin M
PLoS One; 2008 Jan; 3(1):e1413. PubMed ID: 18183294
[TBL] [Abstract][Full Text] [Related]
5. EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG.
Collin M; Olsén A
EMBO J; 2001 Jun; 20(12):3046-55. PubMed ID: 11406581
[TBL] [Abstract][Full Text] [Related]
6. Fragments of bacterial endoglycosidase s and immunoglobulin g reveal subdomains of each that contribute to deglycosylation.
Dixon EV; Claridge JK; Harvey DJ; Baruah K; Yu X; Vesiljevic S; Mattick S; Pritchard LK; Krishna B; Scanlan CN; Schnell JR; Higgins MK; Zitzmann N; Crispin M
J Biol Chem; 2014 May; 289(20):13876-89. PubMed ID: 24668806
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of Streptococcus pyogenes EndoS, an immunomodulatory endoglycosidase specific for human IgG antibodies.
Trastoy B; Lomino JV; Pierce BG; Carter LG; Günther S; Giddens JP; Snyder GA; Weiss TM; Weng Z; Wang LX; Sundberg EJ
Proc Natl Acad Sci U S A; 2014 May; 111(18):6714-9. PubMed ID: 24753590
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic autoantibody glycan hydrolysis alleviates autoimmunity against type VII collagen.
Hirose M; Vafia K; Kalies K; Groth S; Westermann J; Zillikens D; Ludwig RJ; Collin M; Schmidt E
J Autoimmun; 2012 Dec; 39(4):304-14. PubMed ID: 22652418
[TBL] [Abstract][Full Text] [Related]
9. The IgG-specific endoglycosidases EndoS and EndoS2 are distinguished by conformation and antibody recognition.
Sudol ASL; Crispin M; Tews I
J Biol Chem; 2024 May; 300(5):107245. PubMed ID: 38569940
[TBL] [Abstract][Full Text] [Related]
10. IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis.
Benkhoucha M; Molnarfi N; Santiago-Raber ML; Weber MS; Merkler D; Collin M; Lalive PH
J Neuroinflammation; 2012 Sep; 9():209. PubMed ID: 22943418
[TBL] [Abstract][Full Text] [Related]
11. Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.
Huang W; Giddens J; Fan SQ; Toonstra C; Wang LX
J Am Chem Soc; 2012 Jul; 134(29):12308-18. PubMed ID: 22747414
[TBL] [Abstract][Full Text] [Related]
12. IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis.
van Timmeren MM; van der Veen BS; Stegeman CA; Petersen AH; Hellmark T; Collin M; Heeringa P
J Am Soc Nephrol; 2010 Jul; 21(7):1103-14. PubMed ID: 20448018
[TBL] [Abstract][Full Text] [Related]
13. The IgG-specific endoglycosidase EndoS inhibits both cellular and complement-mediated autoimmune hemolysis.
Allhorn M; Briceño JG; Baudino L; Lood C; Olsson ML; Izui S; Collin M
Blood; 2010 Jun; 115(24):5080-8. PubMed ID: 20357243
[TBL] [Abstract][Full Text] [Related]
14. Structural insights into the mechanisms and specificities of IgG-active endoglycosidases.
Du JJ; Klontz EH; Guerin ME; Trastoy B; Sundberg EJ
Glycobiology; 2020 Mar; 30(4):268-279. PubMed ID: 31172182
[TBL] [Abstract][Full Text] [Related]
15.
Naegeli A; Bratanis E; Karlsson C; Shannon O; Kalluru R; Linder A; Malmström J; Collin M
J Exp Med; 2019 Jul; 216(7):1615-1629. PubMed ID: 31092533
[No Abstract] [Full Text] [Related]
16. Toward Clinical use of the IgG Specific Enzymes IdeS and EndoS against Antibody-Mediated Diseases.
Collin M; Björck L
Methods Mol Biol; 2017; 1535():339-351. PubMed ID: 27914091
[TBL] [Abstract][Full Text] [Related]
17. Liquid-liquid diffusion crystallization improves the X-ray diffraction of EndoS, an endo-β-N-acetylglucosaminidase from Streptococcus pyogenes with activity on human IgG.
Trastoy B; Lomino JV; Wang LX; Sundberg EJ
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Dec; 69(Pt 12):1405-10. PubMed ID: 24316841
[TBL] [Abstract][Full Text] [Related]
18. IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment?
Lood C; Allhorn M; Lood R; Gullstrand B; Olin AI; Rönnblom L; Truedsson L; Collin M; Bengtsson AA
Arthritis Rheum; 2012 Aug; 64(8):2698-706. PubMed ID: 22392566
[TBL] [Abstract][Full Text] [Related]
19. Study of the IgG endoglycosidase EndoS in group A streptococcal phagocyte resistance and virulence.
Sjögren J; Okumura CY; Collin M; Nizet V; Hollands A
BMC Microbiol; 2011 May; 11():120. PubMed ID: 21619648
[TBL] [Abstract][Full Text] [Related]
20. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins.
Collin M; Olsén A
Infect Immun; 2001 Nov; 69(11):7187-9. PubMed ID: 11598100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
